Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Acute Cardiac Care|March 25, 2014
Networks for improving care in patients with acute coronary syndrome: A frameworkPeter W Radke, Sigrun Halvorsen, J Wouter Jukema, et al.European Heart Journal|August 19, 2005
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-upDebabrata Mukherjee, Eric J Topol, Michel E Bertrand, et al.European Heart Journal|April 10, 2009
Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 hMartin Busk, Anne Kaltoft, Søren S Nielsen, et al.European Heart Journal|January 29, 2009
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of CardiologyWiktor Kuliczkowski, Adam Witkowski, Lech Polonski, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 8, 2014
Randomised comparison of manual compression and FemoSeal™ vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) studyNiels R Holm, Birthe Sindberg, Mia Schou, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 16, 2026
Transcatheter aortic valve thrombosisMia Ravn Jacobsen, Daniël C Overduin, Rikke Sørensen, et al.Circulation. Cardiovascular Interventions|June 10, 2015
Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trialMartial Hamon, Pierre Coste, Arnoud Van't Hof, et al.JACC. Cardiovascular Interventions|January 25, 2015
Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography)Peter Clemmensen, Sebastian Wiberg, Arnoud Van't Hof, et al.Thrombosis and Haemostasis|August 18, 2019
Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and PracticeTobias Geisler, Rezo Jorbenadze, Aron-Frederik Popov, et al.Journal of the American College of Cardiology|April 25, 2015
Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE TrialKatrin A Fiedler, Michael Maeng, Julinda Mehilli, et al.Pageof 9